Search - tctmd.com

Displaying 181 - 200 of 1387

Sort: Relevancy | Date

Presentation TCT 2016

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Comprehensive CT Algorithm Before TAVR

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, João L Cavalcante

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

Presentation TCT 2016

Venezuela Presents: A Case of a TAVR Complication

Presenter: Juan F. Granada, Oscar A. Mendiz, Carlos D Calderas

November 01, 2016

Presentation TCT 2016

Argentina Presents: A Case of a TAVR Complication

Presenter: Juan F. Granada, Oscar A. Mendiz

November 01, 2016

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

News Industry News

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

November 01, 2016

Presentation TCT 2016

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas

November 01, 2016

Presentation TCT 2016

Saudi Arabia Presents: A Case of Coronary Compression After TAVR

Presenter: Juan F. Granada, Oscar A. Mendiz, Fawaz AlMotairi

November 01, 2016

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

Saudi Arabia Presents: A Case When TAVR Crashes

Presenter: Juan F. Granada, Oscar A. Mendiz, Khaled F Al-Shaibi

November 01, 2016

Presentation TCT 2016

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

Presenter: Ted Feldman, David Hildick-Smith, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Advertisement

Post-TAVR Valve Thickening: Current Data and Open Questions

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Comprehensive CT Algorithm Before TAVR

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Venezuela Presents: A Case of a TAVR Complication

Argentina Presents: A Case of a TAVR Complication

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Saudi Arabia Presents: A Case of Coronary Compression After TAVR

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Saudi Arabia Presents: A Case When TAVR Crashes

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content